The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Role of HE4, CA125, and ultrasound in risk assessment in pelvic mass patients: Results from a prospective, multicentric study.
 
Elena Ioana Braicu
Honoraria - AstraZeneca; Fujirebio Diagnostics; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Research Funding - Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - Amgen/Dompé; Fresenius Biotech; Glycotope GmbH; Medac; Roche Pharma AG
 
Uwe Torsten
Travel, Accommodations, Expenses - AstraZeneca
 
Herbert Mecke
No Relationships to Disclose
 
Rolf Richter
No Relationships to Disclose
 
Kerstin Ames
No Relationships to Disclose
 
Lars Hellmeyer
No Relationships to Disclose
 
Kati Hasenbein
No Relationships to Disclose
 
Gerhard Nohe
No Relationships to Disclose
 
Frank Chen
Honoraria - Merck
 
Carmen Rosa Beteta
No Relationships to Disclose
 
Ricarda Isermann
No Relationships to Disclose
 
Radoslav Chekerov
Honoraria - AstraZeneca; GlaxoSmithKline
Travel, Accommodations, Expenses - Fresenius Biotech; Medac
 
Marcelo Bustamante
No Relationships to Disclose
 
Anna-Maria Dueckelmann
No Relationships to Disclose
 
Miriam Christophi
No Relationships to Disclose
 
Mueller Bodo
No Relationships to Disclose
 
N. Monetaer
No Relationships to Disclose
 
Mathias Zimmermann
No Relationships to Disclose
 
Janine Bonness-Zaloum
No Relationships to Disclose
 
Jalid Sehouli
Honoraria - AstraZeneca; Fresenius Biotech; PharmaMar; Roche Pharma AG
Consulting or Advisory Role - AstraZeneca; Fresenius Biotech; GlaxoSmithKline; PharmaMar
Research Funding - GlaxoSmithKline (Inst); Roche Pharma AG (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Roche Pharma AG